NBS-C  BioScience 
Allergy Research

Building upon special expertise in the field of IgE mediated allergic diseases (allergic asthma, allergic rhinitis, atopic dermatitis, food allergies) NBS-C BioScience offers partnership in allergy research and development with an extended technical portfolio, e.g. establishment of assays for the identification and functional characterization of anti-allergic compounds (biologics and low molecular weight compounds) for low, medium and high throughput format.

Risk assessment during late research phases  and pre-clinical development of investigational drugs or treatments as well as nutritives or cosmetics by in vitro evaluation of their  potency to induce anaphylactic reactions (recombinant cell assays) and ex vivo establishment of  anaphylactogenic risk  profiles  (anaphylactic  shockunder clinically relevant conditions.